Glenmark Pharmaceuticals
GLENMARK.NS
#2572
Rank
โ‚น459.96 B
Marketcap
โ‚น1,630
Share price
-0.57%
Change (1 day)
83.31%
Change (1 year)

EPS for Glenmark Pharmaceuticals (GLENMARK.NS)

EPS in 2023 (TTM): โ‚น9.02

According to Glenmark Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is โ‚น9.41. In 2022 the company made an earnings per share (EPS) of โ‚น33.34 a decrease over its 2021 EPS that were of โ‚น41.78.

EPS history for Glenmark Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น9.02-72.95%
2022โ‚น33.34-20.18%
2021โ‚น41.787.13%
2020โ‚น39.0025.72%
2019โ‚น31.02-22.01%
2018โ‚น39.7730.15%
2017โ‚น30.56-34.82%
2016โ‚น46.8863.09%
2015โ‚น28.759.68%
2014โ‚น26.21-26.58%
2013โ‚น35.700.51%
2012โ‚น35.52